Economic analysis of Lixisenatide in Diabetes Mellitus Type 2
Usage of glucagon like peptide-1 receptors’ agonists (aGLP-1) is a new step in the treatment of Diabetes Mellitus Type 2 (DM 2). General attractive effects are positive effect on bodyweight, lower risk of hypoglycemia, compliance and possibility of combination with insulin or it’s analogues etc. Cli...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
Izdatelstvo OKI
2018-05-01
|
| Seri Bilgileri: | Качественная клиническая практика |
| Konular: | |
| Online Erişim: | https://www.clinvest.ru/jour/article/view/113 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|